A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Children's Oncology Group
Children's Oncology Group
Astellas Pharma Inc
Delta-Fly Pharma, Inc.
Astellas Pharma Inc
National Cancer Institute (NCI)
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Children's Oncology Group
Cornerstone Pharmaceuticals
St. Jude Children's Research Hospital
Children's Oncology Group
University of Ulm
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
Roswell Park Cancer Institute
Dutch Childhood Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Ulm